Director Mahendra Shah sold Verona Pharma plc ($VRNA) shares once on the open market in the last year for a total of about $47,400. His most recent sale occurred on August 1, 2025. These sales rank 10,449th among 11,678 insiders, well below the average of 8.6 million per insider across 6.4 transactions. Shah made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | D | Ordinary Shares | 93472 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | M | Ordinary Shares | 24000 | $0.00 | 97,080.0000 | 727,223,000 | 32.84% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | S | Ordinary Shares | 3608 | $13.14 | 93,472.0000 | 727,223,000 | 3.72% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| April 25, 2025 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| June 12, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | SHAH MAHENDRA | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2024 | Verona Pharma plc | $VRNA | SHAH MAHENDRA | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |